-+ 0.00%
-+ 0.00%
-+ 0.00%

CAN-FITE REPORTS TEN-YEAR SURVIVAL MILESTONE FOR ADVANCED LIVER CANCER PATIENT FROM PHASE II NAMODENOSON STUDY

Reuters·11/09/2026 12:00:06

Please log in to view news